Target intelligence / Profile preview

MIR124-1 host gene (MIR124-1HG)

Target
MIR124-1HG
Molecular classification
Long non-coding RNA (lncRNA), long intergenic non-protein coding RNA
01

Overview

MIR124-1 host gene (MIR124-1HG, also known as Rncr3, LINC00599, and others) is a long non-coding RNA (lncRNA) locus that serves as the host for microRNA miR-124-1. MIR124-1HG is primarily expressed in neural stem/progenitor cells, playing a critical role in neural development by promoting their proliferation and survival while inhibiting premature differentiation. Methylation of MIR124-1HG exons and binding by MeCP2 protein suppress the processing of embedded miR-124a, a highly abundant neuronal miRNA that drives terminal neuronal differentiation. Disruption of MIR124-1HG function or deletion in mice leads to reduced brain size, increased progenitor cell apoptosis, and defective neurogenesis. Dysregulation of this lncRNA has also been linked to cancer (e.g., glioma, prostate cancer) and possibly metabolic diseases. Note: - MIR124-1HG is a regulatory non-coding RNA and not itself a protein-coding therapeutic target such as a receptor, enzyme, or transporter, so it is not conventionally considered a direct therapeutic target. - No approved drugs, biomarkers, or direct mechanisms of action via small molecule or antibody drugs for this lncRNA are currently documented. - Alterations in MIR124-1HG or related pathways may nonetheless provide targets for future therapeutic or diagnostic strategies, especially in neurodevelopmental or neuro-oncological contexts.

Other names
Rncr3neuroLNCretinal non-coding RNA 3neuron-specific nuclear lncRNALINC00599long intergenic non-protein coding RNA 599
02

Biological functions

Regulation of neural stem/progenitor cell proliferation and survivalmodulation of neuronal differentiationcontrol of miR-124a biogenesisepigenetic regulation via methylation and protein interactionsparticipation in post-transcriptional gene silencing and synaptic plasticity
03

Disease associations

Neurodevelopmental defects (e.g., microcephaly)neurodegenerationcancer (glioma, prostate cancer)potentially diabetes mellitus
04

Safety considerations

Potential risk if targeted for therapy includes detrimental effects on neural developmentincreased neuronal apoptosisbrain size reductiontumor growth modulation

Beyond the preview

Go deeper on MIR124-1 host gene (MIR124-1HG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MIR124-1 host gene (MIR124-1HG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call